New York, New York (PRWEB) June 18, 2014
As transvaginal mesh lawsuits (http://www.transvaginalmeshlawsuithelp.com/) continue to move forward in U.S. courts, Bernstein Liebhard LLP notes that Scotland’s Health Secretary is now pushing for a suspension of all transvaginal mesh surgeries in that country, amid growing questions about the safety of such devices. According to a June 17th report from the BBC, Alex Neil asked Scotland’s chief medical officer to write to provincial health boards to request that they immediately suspend the procedures until results from a newly-launched Scottish review, as well as another being conducted by the European Commission, become available next year. At least 14 of Scotland’s health boards have agreed to Neil’s request, while others stated that such procedures had not been used in some time, the BBC said.*
“Our Firm is representing hundreds of women who have allegedly suffered the types of vaginal mesh complications that prompted the Scottish Health Secretary to act. The BBC report just illustrates how widespread these problems are,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm continues to offer free transvaginal mesh lawsuit reviews to women who suffered mesh erosion, pain, scarring, infection and other serious injuries, allegedly due to products manufactured by American Medical Systems, Inc., Boston Scientific Corp., C.R. Bard, Inc. and Ethicon, Inc.
Transvaginal Mesh Lawsuits
Transvaginal mesh products are used in the surgical repair of pelvic organ prolapse and stress urinary incontinence. The U.S. Food & Drug Administration (FDA) launched a review of such products in October 2008, when it first alerted the public to the serious risk of vaginal mesh complications associated with these products. In April, the agency proposed reclassifying transvaginal mesh used to treat pelvic organ prolapse as high-risk medical devices, which would subject the devices to greater regulatory scrutiny.
According to court documents, more than 50,000 transvaginal mesh lawsuits are pending in several litigations now underway in U.S. District Court, Southern District of West Virginia. All of these lawsuits allege that the defendants’ transvaginal mesh devices were defectively designed and manufactured, and were marketed without adequate warnings regarding their risks. Bernstein Liebhard LLP partner, Jeffrey S. Grand, is serving on the Plaintiffs’ Steering Committees for several of these litigations, including those involving American Medical Systems, Inc. (MDL No. 2325), Boston Scientific Corp. (MDL No. 2326), C.R. Bard, Inc. (MDL No. 2187) and Ethicon, Inc. (MDL No. 2327).
Mr. Grand has also been appointed Co-Liaison Counsel in two multicounty litigations underway in New Jersey Superior Court for transvaginal mesh lawsuits involving products marketed by C.R. Bard and Ethicon. He was also a member of the Plaintiff’s trial team on the first Ethicon trial in that proceeding, which ended in March with a jury awarding $11 million in compensatory and punitive damages to a woman who was harmed by the Ethicon Gynecare Prolift device. (In re: Pelvic Mesh/Gynecare Litigation, No. 6341-10; In re: Pelvic Mesh Litigation/Bard, No. L-6339-10)
Alleged victims of serious vaginal mesh complications may be eligible to obtain compensation for their medical bills, lost wages, pain and suffering, emotional distress, and other injury-related damages. To learn more about filing a transvaginal mesh lawsuit, please visit Bernstein Liebhard LLP's website or the Firm's Facebook page: https://www.facebook.com/meshlawsuit. To obtain a free, confidential and no-obligation case review, please call 800-511-5092.
*bbc.com/news/uk-scotland-scotland-politics-27884794, BBC, June 17, 2014
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP represents the victims of defective drugs and medical devices on a contingency-fee basis, and our clients are never expected to pay attorneys fees unless their case results in a successful recovery on their behalf. New York State’s contingency fee cap rules generally limit those fees to 33 1/3% of the total recovery. As a result, the Firm’s fees can be significantly lower than those assessed by attorneys in other states, which depending on the law may amount to as much as 40% or more of a plaintiff’s recovery.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP